Walling J - Search Results

1

A phase II study of sulofenur (LY186641) in gastric cancer.

Kamthan A, Scarffe JH, Walling J, Hatty S, Peters B, Coleman R, Smyth JF. Kamthan A, et al. Among authors: walling j. Anticancer Drugs. 1992 Aug;3(4):331-5. doi: 10.1097/00001813-199208000-00003. Anticancer Drugs. 1992. PMID: 1421428 Clinical Trial.

2

A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer.

O'Brien ME, Hardy J, Tan S, Walling J, Peters B, Hatty S, Wiltshaw E. O'Brien ME, et al. Among authors: walling j. Cancer Chemother Pharmacol. 1992;30(3):245-8. doi: 10.1007/BF00686324. Cancer Chemother Pharmacol. 1992. PMID: 1628377 Clinical Trial.

3

Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer.

Talbot DC, Smith IE, Nicolson MC, Powles TJ, Button D, Walling J. Talbot DC, et al. Among authors: walling j. Cancer Chemother Pharmacol. 1993;31(5):419-22. doi: 10.1007/BF00686159. Cancer Chemother Pharmacol. 1993. PMID: 8431978 Clinical Trial.

4

A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.

Anderson H, Thatcher N, Walling J, Hansen H. Anderson H, et al. Among authors: walling j. Br J Cancer. 1996 Aug;74(3):460-2. doi: 10.1038/bjc.1996.382. Br J Cancer. 1996. PMID: 8695365 Free PMC article. Clinical Trial.

5

A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.

Carmichael J, Allerheiligen S, Walling J. Carmichael J, et al. Among authors: walling j. Semin Oncol. 1996 Oct;23(5 Suppl 10):55-9. Semin Oncol. 1996. PMID: 8893883 Clinical Trial.

6

Phase II activity of gemcitabine in advanced breast cancer.

Carmichael J, Walling J. Carmichael J, et al. Among authors: walling j. Semin Oncol. 1996 Oct;23(5 Suppl 10):77-81. Semin Oncol. 1996. PMID: 8893887 Clinical Trial.

7

A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.

McDonald AC, Vasey PA, Adams L, Walling J, Woodworth JR, Abrahams T, McCarthy S, Bailey NP, Siddiqui N, Lind MJ, Calvert AH, Twelves CJ, Cassidy J, Kaye SB. McDonald AC, et al. Among authors: walling j. Clin Cancer Res. 1998 Mar;4(3):605-10. Clin Cancer Res. 1998. PMID: 9533527 Clinical Trial.

8

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Anderson H, Lund B, Bach F, Thatcher N, Walling J, Hansen HH. Anderson H, et al. Among authors: walling j. J Clin Oncol. 1994 Sep;12(9):1821-6. doi: 10.1200/JCO.1994.12.9.1821. J Clin Oncol. 1994. PMID: 8083706 Clinical Trial.

9

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis.

Budman DR, Johnson R, Barile B, Bowsher RR, Vinciguerra V, Allen SL, Kolitz J, Ernest CS 2nd, Kreis W, Zervos P, Walling J. Budman DR, et al. Among authors: walling j. Cancer Chemother Pharmacol. 2001 Jun;47(6):525-31. doi: 10.1007/s002800000272. Cancer Chemother Pharmacol. 2001. PMID: 11459206 Clinical Trial.

10

Clinical studies with MTA.

Calvert AH, Walling JM. Calvert AH, et al. Among authors: walling jm. Br J Cancer. 1998;78 Suppl 3(Suppl 3):35-40. doi: 10.1038/bjc.1998.752. Br J Cancer. 1998. PMID: 9717989 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters